OPRM1 and cancer: Buprenorphine is an increasingly popular alternative to traditional full MOR agonists (e.g., morphine, oxycodone, fentanyl) for managing cancer-related pain, primarily due to clinician perceptions of a superior side effect profile and safety profile [21].